GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » Asset Turnover
中文

Galapagos NV (Galapagos NV) Asset Turnover : -0.05 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Galapagos NV Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Galapagos NV's Revenue for the three months ended in Dec. 2023 was $-228.1 Mil. Galapagos NV's Total Assets for the quarter that ended in Dec. 2023 was $4,751.2 Mil. Therefore, Galapagos NV's Asset Turnover for the quarter that ended in Dec. 2023 was -0.05.

Asset Turnover is linked to ROE % through Du Pont Formula. Galapagos NV's annualized ROE % for the quarter that ended in Dec. 2023 was 23.51%. It is also linked to ROA % through Du Pont Formula. Galapagos NV's annualized ROA % for the quarter that ended in Dec. 2023 was 14.47%.


Galapagos NV Asset Turnover Historical Data

The historical data trend for Galapagos NV's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Asset Turnover Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.09 0.04 0.05 0.05

Galapagos NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.04 0.03 0.03 -0.05

Competitive Comparison of Galapagos NV's Asset Turnover

For the Biotechnology subindustry, Galapagos NV's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Asset Turnover falls into.



Galapagos NV Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Galapagos NV's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=261.422/( (5015.202+4751.795)/ 2 )
=261.422/4883.4985
=0.05

Galapagos NV's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-228.052/( (4750.625+4751.795)/ 2 )
=-228.052/4751.21
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Galapagos NV  (NAS:GLPG) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Galapagos NV's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=687.28/2923.2115
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(687.28 / -912.208)*(-912.208 / 4751.21)*(4751.21/ 2923.2115)
=Net Margin %*Asset Turnover*Equity Multiplier
=-75.34 %*-0.192*1.6253
=ROA %*Equity Multiplier
=14.47 %*1.6253
=23.51 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Galapagos NV's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=687.28/4751.21
=(Net Income / Revenue)*(Revenue / Total Assets)
=(687.28 / -912.208)*(-912.208 / 4751.21)
=Net Margin %*Asset Turnover
=-75.34 %*-0.192
=14.47 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Galapagos NV Asset Turnover Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV (Galapagos NV) Business Description

Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.